Our Story

Our Story

Real voices. Real impact. Trusted care in action.

A growing community built on advancing care.

Precision and quality built into every detail.

hear from our leadership team micro-tech

From China to the world—driven by purpose and trust.

2000

MICRO-TECH was founded in Nanjing, China to advance minimally invasive medical technology.

2003

The company obtained CE certifications for its esophageal stents and biopsy forceps, kickstarting its global expansion.

2007

MICRO-TECH Europe was established in Germany as the company’s first overseas subsidiary.

2015

MICRO-TECH USA was set up, marking the company’s entry into the North American market.The company acquired a controlling stake in Canyon Medical, entering the field of tumor ablation.

2018

MICRO-TECH Europe became a wholly owned subsidiary for closer global integration.

2019

The company was listed on the Shanghai Stock Exchange STAR Market and entered a new phase of growth and innovation.

2020–2023

Global expansion accelerated with new subsidiaries in the Netherlands, the UK, France, and Japan.

Acquisitions of Endotécnica – Material Cirúrgico (Portugal) and Medexx Medical (Switzerland) reinforced MICRO-TECH’s European presence.

2024

A new production facility was set up in China, and construction of the Thailand Manufacturing Center began.

A representative office was established in Sydney, Australia to further extend MICRO-TECH’s Asia-Pacific presence.

2025

The company acquired Creo Medical S.L.U. (Spain) to strengthen its therapeutic capabilities and strategic position in Europe.

2026

The Thailand Manufacturing Center became operational – a major milestone in MICRO-TECH’s global manufacturing strategy.

Trusted by clinicians. Built for patients.
Designed to make a difference for life.

Trusted by clinicians. Built for patients. Designed to make a difference for life.